ARTICLE | Clinical News
Aplidin regulatory update
November 2, 2016 5:50 PM UTC
EMA accepted for review an MAA for Aplidin plitidepsin from PharmaMar to treat relapsed or refractory multiple myeloma (MM) in combination with dexamethasone. The company said it expects a decision in...